Health Condition 1: E559- Vitamin D deficiency, unspecified
Conditions
Interventions
Intervention1: Vitamin D3: The total duration of the systematic review is intended to be six months from the day of ethics committee approval
All available pharmaceutical preparations not restricted
1
Sponsors
Shakeeb S Dhorajiwala
Eligibility
Inclusion criteria
Inclusion criteria: 1. Study design Systematic review Randomized controlled Clinical trials published trial reports
Exclusion criteria
Exclusion criteria: 1. Studies not published in English 2. Studies with insufficient data for analysis. 3. Studies not published 4. Paid access to publication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 All cause mortality 2 Cardiovascular events 3 Cancer outcome 4 Inflammatory conditions 5 Respiratory Outcomes Timepoint: all outcomes will be subjected to metanalysis within six months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Other Health Conditions: 1.1 Cognitive function (e.g., executive function) 1.2 Functional outcomes 1.3 Wellbeing 1.4 Risk of infection (any, bacterial vaginosis) 1.5 Tuberculosis cure rate 1.6 Sputum smear or culture positivity in tuberculosis patients 1.7 CD4 cell count in HIV patients with tuberculosis 2.Adverse Events: 2.1 Renal stone formation 2.2 Elevated blood levels of calcium (hypercalcemia) 2.3 Hypercalciuria 2.4 Vomiting (in COVID-19 patients) 2.5 Serious adverse eventsTimepoint: all secondary outcomes will be subjected to metanalysis within six months | — |
Countries
India
Contacts
Public ContactShakeeb Siraj Dhorajiwala
Seth GSMC and Kem hospital
Outcome results
None listed